in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Merck KGaA May Divest Generics
1:07 PM MDT | July 18, 2007 | Chemical Week Editorial Staff
Merck KGaA is considering plans to divest its generic drugs business and could raise up to €4 billion ($5.3 billion) from the sale, according to a report in German newspaper Handelsblatt on January 4. Merck KGaA declined to comment on the report. Selling generics would cut Merck KGaA’s debt following the company’s imminent purchase of biotechnology firm Serono for over $13 billion. Private equity firms, rather than pharmaceutical manufacturers, are more likely to be interested in buying Merck KGaA’s generics, analysts say. Merck KGaA is one...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee